CBDMD INC
YCBDNYSE AMERICANTrading Snapshot
- Day Range
- $0.34 β $0.37
- 52-Week Range
- $0.33 β $2.56
- Volume (shares)
- 121,296
- Avg Volume (shares)
- β
- Shares Outstanding
- 11.2M
- Next Earnings
- 2026-12-18
Fundamentals Snapshot
- Annual Revenue
- $19M
- Last Q Revenue
- $6M
- P/E Ratio
- β
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-0.29
- Dividend Yield
- β
- Dilution (1yr)
- +97.8%
CBDMD INC
YCBDAbout CBDMD INC
cbdMD, Inc. is engaged in the production and distribution of a diverse array of cannabidiol (CBD) products. The company oversees and markets several consumer-oriented, hemp-derived CBD brands, notably its primary brand cbdMD, alongside Paw CBD and cbdMD Botanicals. Under the cbdMD label, its offerings span various items, including CBD tinctures, edible gummies, topical applications, capsules, bath bombs, bath salts, and solutions designed to aid sleep. Furthermore, its Paw CBD brand caters to pets with veterinarian-formulated products such as tinctures, edible chews, and topical treatments. The company's merchandise reaches customers throughout the United States via its proprietary e-commerce platform, various third-party online retail sites, wholesale partners, and physical brick-and-mortar establishments. cbdMD, Inc. also maintains a research collaboration with the University of Mississippi, focusing on the discovery of novel cannabinoids. Incorporated in 2015, the firm was previously known as Level Brands, Inc. before officially changing its name to cbdMD, Inc. in May 2019, and its corporate headquarters are situated in Charlotte, North Carolina.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Analyst Ratings
βLatest News & Updates

Reserveage Launches Longev+ Exclusively at The Vitamin Shoppe, Bringing Strength Into the Healthy Aging Conversation
New formula combines amino acids, HMB, creatine and resveratrol as Twinlab brands await proposed acquisition by cbdMD CHARLOTTE, N.C., Sept. 24, 2026 /PRNewswire/ -- Reserveage, part of the Twinlab family of brands, anno

cbdMD (NYSEAMERICAN:YCBD) Trading Up 5.1% β Whatβs Next?
cbdMD, Inc. (NYSEAMERICAN:YCBD - Get Free Report) traded up 5.1% on Tuesday. The stock traded as high as $0.4998 and last traded at $0.4997. Approximately 34,350 shares changed hands during mid-day trading, a decline of

cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness
Agreement will add iconic supplement brands to cbdMD's growing multi-brand consumer wellness platform, anticipated to increase revenues to approximately $30 million. CHARLOTTE, N.C.